Filed: 5/15/2026ACC: 0001636587-26-000029
📋 What this filing means
ACORN CAPITAL ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 22 equity positions with a total reported market value of $351.84M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
22
Positions
$351.84M
Total AUM (reported)
35.14M
Total Shares
Allocation by class
COM$304.38M86.5%
COM STK$16.52M4.7%
CLASS A COM$11.76M3.3%
COM NEW$11.05M3.1%
COMMON STOCK$8.13M2.3%
Portfolio Concentration
Top 3$198.73M56.5%
4–10$113.93M32.4%
11–25$39.17M11.1%
Top 3 weight
56.5%
Top 10 weight
88.9%
Voting Authority Distribution
Total shares with voting rights: 35.14M
Sole
Full voting authority
35.14M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole22
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings22
Rows:
TERNS PHARMACEUTICALS INC
SOLEShares1.75M
TypeSH
Market value$92.06M
26.17%
Sole
1.75M
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares1.13M
TypeSH
Market value$76.58M
21.77%
Sole
1.13M
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares1.67M
TypeSH
Market value$30.09M
8.55%
Sole
1.67M
Shared
0.00
None
0.00
PUMA BIOTECHNOLOGY INC
SOLEShares4.13M
TypeSH
Market value$26.40M
7.50%
Sole
4.13M
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares2.14M
TypeSH
Market value$25.59M
7.27%
Sole
2.14M
Shared
0.00
None
0.00
CANDEL THERAPEUTICS INC
SOLEShares3.50M
TypeSH
Market value$17.21M
4.89%
Sole
3.50M
Shared
0.00
None
0.00
BICARA THERAPEUTICS
SOLEShares643.38K
TypeSH
Market value$12.80M
3.64%
Sole
643.38K
Shared
0.00
None
0.00
ONKURE THERAPEUTICS INC
SOLEShares2.84M
TypeSH
Market value$11.76M
3.34%
Sole
2.84M
Shared
0.00
None
0.00
JADE BIOSCEINCES INC
SOLEShares786.76K
TypeSH
Market value$11.05M
3.14%
Sole
786.76K
Shared
0.00
None
0.00
PROTARA THERAPEUTICS INC
SOLEShares1.75M
TypeSH
Market value$9.13M
2.59%
Sole
1.75M
Shared
0.00
None
0.00
VERASTEM INC
SOLEShares1.47M
TypeSH
Market value$7.79M
2.21%
Sole
1.47M
Shared
0.00
None
0.00
HELUS PHARMA INC.
SOLEShares1.54M
TypeSH
Market value$7.39M
2.10%
Sole
1.54M
Shared
0.00
None
0.00
LEONABIO, INC.
SOLEShares634.54K
TypeSH
Market value$6.52M
1.85%
Sole
634.54K
Shared
0.00
None
0.00
AURA BIOSCIENCES INC
SOLEShares595.74K
TypeSH
Market value$3.99M
1.13%
Sole
595.74K
Shared
0.00
None
0.00
WHITEHAWK THERAPEUTICS INC
SOLEShares1.14M
TypeSH
Market value$3.93M
1.12%
Sole
1.14M
Shared
0.00
None
0.00
CARDIF ONCOLOGY INC
SOLEShares1.76M
TypeSH
Market value$2.85M
0.81%
Sole
1.76M
Shared
0.00
None
0.00
Q32 BIO INC.
SOLEShares315.05K
TypeSH
Market value$2.02M
0.57%
Sole
315.05K
Shared
0.00
None
0.00
KARYOPHARM THERAPEUTICS INC
SOLEShares287.83K
TypeSH
Market value$1.60M
0.46%
Sole
287.83K
Shared
0.00
None
0.00
JASPER THERAPEUTICS
SOLEShares1.41M
TypeSH
Market value$1.24M
0.35%
Sole
1.41M
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares234.04K
TypeSH
Market value$966.6K
0.27%
Sole
234.04K
Shared
0.00
None
0.00
BIOATLA INC
SOLEShares5.41M
TypeSH
Market value$865.0K
0.25%
Sole
5.41M
Shared
0.00
None
0.00
VYNE THERAPEUTICS INC
SOLEShares1.43K
TypeSH
Market value$855.00
<0.01%
Sole
1.43K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
TERNS PHARMACEUTICALS INCSOLE | COM | 1.75M | SH | $92.06M 26.17% | 1.75M | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 1.13M | SH | $76.58M 21.77% | 1.13M | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 1.67M | SH | $30.09M 8.55% | 1.67M | 0.00 | 0.00 |
PUMA BIOTECHNOLOGY INCSOLE | COM | 4.13M | SH | $26.40M 7.50% | 4.13M | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 2.14M | SH | $25.59M 7.27% | 2.14M | 0.00 | 0.00 |
CANDEL THERAPEUTICS INCSOLE | COM | 3.50M | SH | $17.21M 4.89% | 3.50M | 0.00 | 0.00 |
BICARA THERAPEUTICSSOLE | COM | 643.38K | SH | $12.80M 3.64% | 643.38K | 0.00 | 0.00 |
ONKURE THERAPEUTICS INCSOLE | CLASS A COM | 2.84M | SH | $11.76M 3.34% | 2.84M | 0.00 | 0.00 |
JADE BIOSCEINCES INCSOLE | COM NEW | 786.76K | SH | $11.05M 3.14% | 786.76K | 0.00 | 0.00 |
PROTARA THERAPEUTICS INCSOLE | COM STK | 1.75M | SH | $9.13M 2.59% | 1.75M | 0.00 | 0.00 |
VERASTEM INCSOLE | COM | 1.47M | SH | $7.79M 2.21% | 1.47M | 0.00 | 0.00 |
HELUS PHARMA INC.SOLE | COM STK | 1.54M | SH | $7.39M 2.10% | 1.54M | 0.00 | 0.00 |
LEONABIO, INC.SOLE | COMMON STOCK | 634.54K | SH | $6.52M 1.85% | 634.54K | 0.00 | 0.00 |
AURA BIOSCIENCES INCSOLE | COM | 595.74K | SH | $3.99M 1.13% | 595.74K | 0.00 | 0.00 |
WHITEHAWK THERAPEUTICS INCSOLE | COM | 1.14M | SH | $3.93M 1.12% | 1.14M | 0.00 | 0.00 |
CARDIF ONCOLOGY INCSOLE | COM | 1.76M | SH | $2.85M 0.81% | 1.76M | 0.00 | 0.00 |
Q32 BIO INC.SOLE | COM | 315.05K | SH | $2.02M 0.57% | 315.05K | 0.00 | 0.00 |
KARYOPHARM THERAPEUTICS INCSOLE | COMMON STOCK | 287.83K | SH | $1.60M 0.46% | 287.83K | 0.00 | 0.00 |
JASPER THERAPEUTICSSOLE | COM | 1.41M | SH | $1.24M 0.35% | 1.41M | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM | 234.04K | SH | $966.6K 0.27% | 234.04K | 0.00 | 0.00 |
BIOATLA INCSOLE | COM | 5.41M | SH | $865.0K 0.25% | 5.41M | 0.00 | 0.00 |
VYNE THERAPEUTICS INCSOLE | COM | 1.43K | SH | $855.00 <0.01% | 1.43K | 0.00 | 0.00 |